14-75003365-T-A
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 9P and 1B. PP3PP5_Very_StrongBS1_Supporting
The NM_014239.4(EIF2B2):c.254T>A(p.Val85Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000385 in 1,611,862 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_014239.4 missense
Scores
Clinical Significance
Conservation
Publications
- leukoencephalopathy with vanishing white matterInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Illumina
- leukoencephalopathy with vanishing white matterInheritance: AR Classification: STRONG Submitted by: G2P
- leukoencephalopathy with vanishing white matter 1Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- ovarioleukodystrophyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000333 AC: 5AN: 150034Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000717 AC: 18AN: 251012 AF XY: 0.0000590 show subpopulations
GnomAD4 exome AF: 0.0000390 AC: 57AN: 1461828Hom.: 0 Cov.: 33 AF XY: 0.0000371 AC XY: 27AN XY: 727194 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000333 AC: 5AN: 150034Hom.: 0 Cov.: 31 AF XY: 0.0000274 AC XY: 2AN XY: 73110 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Leukoencephalopathy with vanishing white matter 2 Pathogenic:3
- -
The NM_014239.4(EIF2B2):c.254T>A variant results in a missense change (p.Val85Glu). This affects a conserved nucleotide and is present with a low frequency (0.0000385) in gnomAD database, with no homozygotes observed. The variant has been reported in individuals with leukoencephalopathy.In silico predictions and advanced protein modeling (Invitae) support a damaging effec. ClinVar classifies this variant as Likely Pathogenic /Pathogenic (Variation ID: 40180). -
PM2_Supporting+PM3_VeryStrong+PS3_Supporting+PP1 -
not provided Pathogenic:1
This sequence change replaces valine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 85 of the EIF2B2 protein (p.Val85Glu). This variant is present in population databases (rs397514648, gnomAD 0.1%). This missense change has been observed in individuals with leukoencephalopathy with vanishing white matter (PMID: 21484434, 25031760, 25843247, 28041799, 29700822). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 40180). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt EIF2B2 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects EIF2B2 function (PMID: 21484434). For these reasons, this variant has been classified as Pathogenic. -
Abnormality of the nervous system Pathogenic:1
- -
Vanishing white matter disease Pathogenic:1
Variant summary: EIF2B2 c.254T>A (p.Val85Glu) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 7.2e-05 in 251012 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in EIF2B2 causing Leukoencephalopathy With Vanishing White Matter (7.2e-05 vs 0.00046), allowing no conclusion about variant significance. c.254T>A has been reported in the literature in multiple homozygous and compound heterozygous individuals affected with Leukoencephalopathy With Vanishing White Matter (Matsukawa_2011, Shimada_2015, Lee_2017, Wei_2019). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function, showing the variant results in ~80% of normal GDP/GTP exchange activity (Matsukawa_2011). Two submitters have provided clinical-significance assessments for this variant to ClinVar after 2014, and classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at